Core Viewpoint - The company,稳健医疗, is celebrating the fifth anniversary of its stock listing by launching a shareholder appreciation event to thank its investors for their support [1] Group 1 - The company plans to conduct a "Shareholder Appreciation Event" to express gratitude to all shareholders [1] - During the event, eligible shareholders can receive exclusive benefit vouchers after identity verification [1] - Shareholders can purchase the company's products at discounted prices in a dedicated appreciation venue [1] - Detailed event information can be accessed through the company's official WeChat account "稳健集团" [1]

稳健医疗公告，2025年上半年营业收入52.96亿元，同比增长31.31%。净利润4.92亿元，同比增长 28.07%。公司经本次董事会审议通过的利润分配预案为：以5.82亿股为基数，向全体股东每10股派发现 金红利4.5元（含税），不送红股，不以公积金转增股本。 ...

Core Viewpoint - The company acknowledges the impact of various factors on its stock price fluctuations and emphasizes its commitment to improving operational performance and shareholder value [1] Group 1 - The company responded to an investor inquiry regarding the latest number of shareholders as of August [1] - The management indicated that shareholder information will be disclosed in regular reports, adhering to the principle of fair information disclosure [1] - The company expressed gratitude for the investor's attention and support [1]

Core Viewpoint - The company,稳健医疗, is experiencing a decline in stock price and profitability, with a significant drop in net profit despite a slight increase in revenue, indicating potential challenges in maintaining growth and profitability in the competitive medical supplies market [1][2]. Company Overview - The company specializes in the research, production, and sales of cotton-based products across various sectors, including medical, personal care, and home care [1]. - Key products include advanced wound dressings, traditional wound care products, infection control products, and a range of personal hygiene items [1]. - The company has consistently ranked among the top three exporters of medical dressings in China and has established a strong presence in domestic hospitals and pharmacies [1]. Financial Performance - For the third quarter of 2024, the company reported a revenue of 6.07 billion yuan, reflecting a year-on-year increase of 0.99% [1]. - Net profit for the same period was 553 million yuan, showing a significant decline of 74.25% year-on-year [1]. - The gross profit margin stood at 48.14%, indicating the company's ability to maintain a healthy margin despite the drop in net profit [1]. Shareholder Information - As of September 30, 2024, the company had 28,966 shareholders, a decrease of 201 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1]. Market Valuation - The company's latest closing price was 43.5 yuan, with a market-to-book ratio of 2.23 and a total market capitalization of 25.331 billion yuan [1][2]. - The company's price-to-earnings ratio (TTM) is reported at -24.97, indicating negative earnings relative to its stock price [2].